Request for Covid-19 Impact Assessment of this Report
Market Dynamics
The rapidly growing penetration of healthcare informaticsis one of the prime drivers for the healthcare cloud computing market. Moreover, higher volume storage capacity, lesser initial investment and nominal technical support required in cloud-based healthcare applications have led to the increased importance of this market.Apart from these factors favorable government initiatives and technological advancements act as growth drivers.
Error limitations and ineffective disaster backup, doubts about the safety of personal data put constraints on the market.
Market Segmentation
The market is segmented in by type of application (Clinical Information Systems, Nonclinical Information Systems), by deployment model (Private cloud, Public cloud and Hybrid cloud), by service model (Software-as-a-service (SaaS), Infrastructure-as-a-service (IaaS) and Platform-as-a-service (PaaS)), by pricing model (Pay-as-you-go and Spot Pricing), by component (Hardware, Software and Services) and by end users (Healthcare Providers and Healthcare Payers).
Geographic Analysis
North America leads the healthcare cloud computing market owing to the frequent technological developments. However, Asia-Pacific is growing rapidly due to reasons like the rise in the number of cloud-ready Asian countries, growing popularity of lean healthcare management and focus on providing sustainable healthcare delivery model.
Key Players
Some of the major players in the market include Microsoft Corporation, International Business Machines Corporation, Dell Inc, and Oracle Corporation, Carestream Health Inc, Merge Healthcare Incorporated, GE Healthcare, Agfa-Gevaert, and CareCloud Corporation.
The report contains comprehensive analysis on:
--> Healthcare Cloud Computing Market Segments
--> Healthcare Cloud Computing Market Drivers, Restraints and Opportunities
--> Healthcare Cloud Computing Market Size & Forecast 2016 to 2022
--> Supply & Demand Value Chain
--> Healthcare Cloud Computing Market Current Trends
--> Competition &Major Companies
--> Technology and R&D Status
--> Porters Five Force Analysis
--> Strategic and Critical Success Factor Analysis of Key Players
Regional analysis for Healthcare Cloud Computing Market includes
--> North America
>> US and Canada
--> Latin America
>> Mexico, Brazil, Argentina and Rest of Latin America
--> Western Europe
>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe
--> Eastern Europe
>> Russia
>> Poland
>> Rest of Eastern Europe
--> Asia Pacific
>> China
>> India
>> Japan
>> Australia and New Zealand
>> Rest of Asia Pacific
--> Middle East and Africa
>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa
This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides in-depth market segmentation that is derived from extensive product mapping exercises, macro-economic factors and other qualitative and quantitative insights. The impact of all such factors are delivered across multiple market segments and geographies.
Report Highlights::
--> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
--> Consumer and Pricing Analysis
--> Market dynamics of the industry
--> In-depth Market Segmentation
--> Historical and Projected Market Sizing in terms of volume and value
--> Recent market trends and Impact Factors
--> R&D Status and Technology Overview
--> Extensive Industry Structure Coverage
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...